Video content above is prompted by the following: Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections? Can you provide an overview of the port delivery system with ranibizumab? How does the device function? How is the device implanted? How is the device refilled? What gives you confidence in using the PDS system despite its recall in 2022 after the initial launch?